Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells

Cell Metabolism

Volumn 23, Issue 5, 2016, Pages 852-866

  Yun, Tae Jin ^a,b   Lee, Jun Seong ^a,c   Machmach, Kawthar ^a,c   Shim, Dahee ^d   Choi, Junhee ^d   Wi, Young Jin ^d   Jang, Hyung Seok ^d   Jung, In Hyuk ^e   Kim, Kyeongdae ^d   Yoon, Won Kee ^f   Miah, Mohammad Alam ^a,c   Li, Bin ^a,c   Chang, Jinsam ^a,c   Bego, Mariana G ^a   Pham, Tram N Q ^a   Loschko, Jakob ^g   Fritz, Jörg Hermann ^b   Krug, Anne B ^g   Lee, Seung Pyo ^h   Keler, Tibor ⁱ   Guimond, Jean V ^j   Haddad, Elie ^c,k   Cohen, Eric A ^a,c   Sirois, Martin G ^c,l   El Hamamsy, Ismail ^l   Colonna, Marco ^m   Oh, Goo Taeg ^e   Choi, Jae Hoon ^d   Cheong, Cheolho ^a,b,c   more..

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Hanyang University   (South Korea)

^e Ewha Womans University   (South Korea)

^f Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^g UNIVERSITY OF MUNICH   (Germany)

^h Seoul National University Hospital   (South Korea)

ⁱ Celldex Therapeutics Inc   (United Kingdom)

^j HYDRO QUÉBEC   (Canada)

^k UNIVERSITY OF MONTREAL   (Canada)

^l MONTREAL HEART INSTITUTE   (Canada)

^m WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD123 ANTIGEN; CD135 ANTIGEN; CHEMOKINE RECEPTOR CCR9; FLT3 LIGAND; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; EPITOPE; FLT3 LIGAND PROTEIN; FLT3 PROTEIN, MOUSE; INTERFERON; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; AORTA INTIMA; ARTICLE; ATHEROSCLEROSIS; CELL EXPANSION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UPREGULATION; ANIMAL; AORTA; BONE MARROW; CELL COUNT; CELL PROLIFERATION; DENDRITIC CELL; DRUG EFFECTS; ENZYMOLOGY; HOMEOSTASIS; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOLOGY; TIME FACTOR; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; AORTA; ATHEROSCLEROSIS; BONE MARROW; CELL COUNT; CELL PROLIFERATION; DENDRITIC CELLS; EPITOPES; FMS-LIKE TYROSINE KINASE 3; HOMEOSTASIS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE I; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; RECEPTORS, LDL; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TOLL-LIKE RECEPTOR 9;

EID: 84966604699     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.04.010     Document Type: Article

References (33)

1. H. Ait-Oufella, B.L. Salomon, S. Potteaux, A.K. Robertson, P. Gourdy, J. Zoll, R. Merval, B. Esposito, J.L. Cohen, S. Fisson, and et al. Natural regulatory T cells control the development of atherosclerosis in mice Nat. Med. 12 2006 178 180
2. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
3. A.L. Blasius, E. Giurisato, M. Cella, R.D. Schreiber, A.S. Shaw, and M. Colonna Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation J. Immunol. 177 2006 3260 3265
4. C. Cheong, and J.H. Choi Dendritic cells and regulatory T cells in atherosclerosis Mol. Cells 34 2012 341 347
5. J.H. Choi, Y. Do, C. Cheong, H. Koh, S.B. Boscardin, Y.S. Oh, L. Bozzacco, C. Trumpfheller, C.G. Park, and R.M. Steinman Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves J. Exp. Med. 206 2009 497 505
6. J.H. Choi, C. Cheong, D.B. Dandamudi, C.G. Park, A. Rodriguez, S. Mehandru, K. Velinzon, I.H. Jung, J.Y. Yoo, G.T. Oh, and R.M. Steinman Flt3 signaling-dependent dendritic cells protect against atherosclerosis Immunity 35 2011 819 831
7. M. Colonna, G. Trinchieri, and Y.J. Liu Plasmacytoid dendritic cells in immunity Nat. Immunol. 5 2004 1219 1226
8. M.I. Cybulsky, C. Cheong, and C.S. Robbins Macrophages and dendritic cells: partners in atherogenesis Circ. Res. 118 2016 637 652
9. I.T. Daissormont, A. Christ, L. Temmerman, S. Sampedro Millares, T. Seijkens, M. Manca, M. Rousch, M. Poggi, L. Boon, C. van der Loos, and et al. Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity Circ. Res. 109 2011 1387 1395
10. A. Defays, A. David, A. de Gassart, F. De Angelis Rigotti, T. Wenger, V. Camossetto, P. Brousset, T. Petrella, M. Dalod, E. Gatti, and P. Pierre BAD-LAMP is a novel biomarker of nonactivated human plasmacytoid dendritic cells Blood 118 2011 609 617
11. Y. Döring, H.D. Manthey, M. Drechsler, D. Lievens, R.T. Megens, O. Soehnlein, M. Busch, M. Manca, R.R. Koenen, J. Pelisek, and et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis Circulation 125 2012 1673 1683
12. A.C. Foks, A.H. Lichtman, and J. Kuiper Treating atherosclerosis with regulatory T cells Arterioscler. Thromb. Vasc. Biol. 35 2015 280 287
13. E.L. Gautier, T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft, A. Chow, K.G. Elpek, S. Gordonov, et al. Immunological Genome Consortium Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages Nat. Immunol. 13 2012 1118 1128
14. H.S. Ghosh, B. Cisse, A. Bunin, K.L. Lewis, and B. Reizis Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells Immunity 33 2010 905 916
15. H. Hadeiba, T. Sato, A. Habtezion, C. Oderup, J. Pan, and E.C. Butcher CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease Nat. Immunol. 9 2008 1253 1260
16. H. Hadeiba, K. Lahl, A. Edalati, C. Oderup, A. Habtezion, R. Pachynski, L. Nguyen, A. Ghodsi, S. Adler, and E.C. Butcher Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance Immunity 36 2012 438 450
17. T.S. Heng, M.W. Painter Immunological Genome Project Consortium The Immunological Genome Project: networks of gene expression in immune cells Nat. Immunol. 9 2008 1091 1094
18. C. Jakubzick, E.L. Gautier, S.L. Gibbings, D.K. Sojka, A. Schlitzer, T.E. Johnson, S. Ivanov, Q. Duan, S. Bala, T. Condon, and et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes Immunity 39 2013 599 610
19. J.M. Kim, J.P. Rasmussen, and A.Y. Rudensky Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice Nat. Immunol. 8 2007 191 197
20. R. Klingenberg, N. Gerdes, R.M. Badeau, A. Gisterå, D. Strodthoff, D.F. Ketelhuth, A.M. Lundberg, M. Rudling, S.K. Nilsson, G. Olivecrona, and et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis J. Clin. Invest. 123 2013 1323 1334
21. P. Liu, Y.R. Yu, J.A. Spencer, A.E. Johnson, C.T. Vallanat, A.M. Fong, C. Patterson, and D.D. Patel CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden Arterioscler. Thromb. Vasc. Biol. 28 2008 243 250
22. N. Macritchie, G. Grassia, S.R. Sabir, M. Maddaluno, P. Welsh, N. Sattar, A. Ialenti, M. Kurowska-Stolarska, I.B. McInnes, J.M. Brewer, and et al. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 32 2012 2569 2579
23. E. Maganto-García, M.L. Tarrio, N. Grabie, D.X. Bu, and A.H. Lichtman Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia Circulation 124 2011 185 195
24. J.C. Ochando, C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V. Angeli, Y. Li, P. Boros, Y. Ding, and et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts Nat. Immunol. 7 2006 652 662
25. M.T. Pallotta, C. Orabona, C. Volpi, C. Vacca, M.L. Belladonna, R. Bianchi, G. Servillo, C. Brunacci, M. Calvitti, S. Bicciato, and et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells Nat. Immunol. 12 2011 870 878
26. P. Puccetti, and U. Grohmann IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation Nat. Rev. Immunol. 7 2007 817 823
27. B. Reizis, M. Colonna, G. Trinchieri, F. Barrat, and M. Gilliet Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat. Rev. Immunol. 11 2011 558 565
28. A.P. Sage, D. Murphy, P. Maffia, L.M. Masters, S.R. Sabir, L.L. Baker, H. Cambrook, A.J. Finigan, H. Ait-Oufella, G. Grassia, and et al. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity Circulation 130 2014 1363 1373
29. A.T. Satpathy, X. Wu, J.C. Albring, and K.M. Murphy Re(de)fining the dendritic cell lineage Nat. Immunol. 13 2012 1145 1154
30. R.M. Steinman Decisions about dendritic cells: past, present, and future Annu. Rev. Immunol. 30 2012 1 22
31. M. Subramanian, E. Thorp, G.K. Hansson, and I. Tabas Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs J. Clin. Invest. 123 2013 179 188
32. M. Swiecki, S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual Immunity 33 2010 955 966
33. H. Watarai, E. Sekine, S. Inoue, R. Nakagawa, T. Kaisho, and M. Taniguchi PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon Proc. Natl. Acad. Sci. USA 105 2008 2993 2998